R. Vargas et al., ANGIOPEPTIN INHIBITS THYMIDINE INCORPORATION BY EXPLANTS OF PORCINE CORONARY-ARTERIES, Journal of cardiovascular pharmacology, 29(2), 1997, pp. 278-283
Angiopeptin, a stable octapeptide analog of somatostatin, inhibits pro
liferation in a variety of cancer cell lines. We studied the effect of
angiopeptin on H-3-thymidine uptake into ring segments from the porci
ne coronary tree. The incorporation of H-3-thymidine into segments of
porcine left anterior descending (LAD) coronary artery was time depend
ent and reached a plateau after 48 h. The addition of angiopeptin (48.
1 and 96.2 nM) to the culture medium significantly inhibited 3H-thymid
ine incorporation into the segments by 36.7 +/- 10.1% and 48.3 +/- 2.3
% of the control, respectively. Forskolin (100 mu M), inhibited H-3-th
ymidine incorporation (52.7 +/- 10.1%) to the same degree as did angio
peptin (96.2 nM). Incubation of the segments with I-125-labeled angiop
eptin, for 2 h at 37 degrees C, showed angiopeptin uptake to be time d
ependent and exhibited a first-order kinetics, reaching equilibrium af
ter 30 min. Autoradiographic studies showed a uniform distribution of
angiopeptin within the endothelium, media, and adventitia. Most of the
labeling was associated with the nuclei of the cells. Angiopeptin, af
ter 30-min incubation, did not significantly modify the basal levels o
f cyclic adenosine monophosphate (cAMP). In contrast, forskolin (100 m
u M) elicited a 50-fold increase of the basal levels of cAMP. These re
sults indicate that in addition to its endocrine effects, angiopeptin
reduces the rate of proliferation by acting directly on the vessel wal
l.